Publication Name	World Journal of Cardiology
Manuscript ID	67919
Country	Greece

Received	2021-05-31 10:26
Peer-Review Started	2021-05-31 10:31
To Make the First Decision
Return for Revision	2021-06-16 22:55
Revised	2021-07-18 15:59
Second Decision	2022-01-11 03:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-11 19:53
Articles in Press	2022-01-11 19:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-01-18 03:45
Publish the Manuscript Online	2022-01-19 06:37

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Role of genetic testing in cardiomyopathies: Α primer for cardiologists
Manuscript Source	Invited Manuscript
All Author List	Georgia Vogiatzi, George Lazaros, Evangelos Oikonomou, Emilia Lazarou, Emmanouil Vavuranakis and Dimitris Tousoulis
Funding Agency and Grant Number
Corresponding Author	Georgia Vogiatzi, PhD, Consultant Physician-Scientist, The Third Department of Cardiology, Sotiria Hospital, Mesogeion 152, Athens 11527, Greece. gvogiatz@yahoo.gr
Key Words	Cardiomyopathy; Genetic counselling; Genetic testing; Variant; Hereditary
Core Tip	In a considerable percentage of patients with cardiomyopathies, there is a genetic component. If the presence or severity of the cardiomyopathy cannot be explained by acquired causes, the genetic component should be investigated in order to reveal potential inherited forms of cardiomyopathies. The genetic testing process is also helpful to minimize potential harms and provide suggestions to specialized clinicians who act as a part of a multidisciplinary team, with the objective of offering the best care to families with inherited cardiomyopathies.
Publish Date	2022-01-19 06:37
Citation	Vogiatzi G, Lazaros G, Oikonomou E, Lazarou E, Vavuranakis E, Tousoulis D. Role of genetic testing in cardiomyopathies: Α primer for cardiologists. World J Cardiol 2022; 14(1): 29-39
URL	https://www.wjgnet.com/1949-8462/full/v14/i1/29.htm
DOI	https://dx.doi.org/10.4330/wjc.v14.i1.29

Full Article (PDF)	WJC-14-29.pdf
Full Article (Word)	WJC-14-29.docx
Manuscript File	67919_Auto_Edited.docx
Answering Reviewers	67919-Answering reviewers.pdf
Audio Core Tip	67919-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	67919-Conflict-of-interest statement.pdf
Copyright License Agreement	67919-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	67919-Language certificate.pdf
Peer-review Report	67919-Peer-review(s).pdf
Scientific Misconduct Check	67919-Bing-Gao CC-1.jpg
Scientific Misconduct Check	67919-Bing-Wang JJ-2.png
Scientific Editor Work List	67919-Scientific editor work list.pdf